Dr. Thomas A. Leavens

M.D. | Neurology


  1307 8th Ave, #408, Fort Worth
     Texas, 76104-4137
  817-921-4191    817-924-3096 Maps & Directions
Dr. Thomas A. Leavens is a Fort Worth, Texas based neurologist who is specialized in Neurology. His current practice location is 1307 8th Ave, #408, Fort Worth. Patients can reach him at 817-921-4191 or can fax him at 817-924-3096. Dr. Thomas A. Leavens is M.D. in Neurology and his NPI number (Unique professional ID assigned by NPPES) is 1114910460.
Dr. Thomas A. Leavens specializes in the diagnosis and treatment of diseases or impaired function of the brain, spinal cord, peripheral nerves, muscles, autonomic nervous system, and blood vessels that relate to these structures.
Complete Profile:
Dr. Thomas A. Leavens speciality, credentials, practice address, contact phone number and fax are as below. Patients can call on the below given phone number for appointment.
Name: Dr. Thomas A. Leavens
Specialization: Neurology
Gender:Male
Credentials: M.D.
Practice Address:1307 8th Ave, #408, Fort Worth,
Texas, 76104-4137
Phone:817-921-4191
Fax:817-924-3096
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS). NPI details are as mentioned below.
NPI Number: 1114910460
NPI Enumeration Date: 23 Aug, 2005
NPI Last Update On: 07 May, 2014

Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: Dr. Thomas A. Leavens
221 W. Colorado Blvd. Pavillion 2, Suite 537
Dallas, Texas
Zip: 75208
Phone Number: 214-943-4599
Fax Number: 214-942-3549
Patients can reach Dr. Thomas A. Leavens at 1307 8th Ave, #408, Fort Worth, Texas or can call to book an appointment on 817-921-4191.
Comments/ Reviews:

Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 11 March, 2024.